AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
Healthcare
Kalkine: FTSE 100 Drops as Geopolitical Tensions and Eurozone Data Pressure Markets
June 13, 2025 05:57 PM AEST| By Team Kalkine MediaHighlights,FTSE,100,opened lower amid reports of Israeli airstrikes in Iran, triggering broad market unease,The British pound declined alongside equities as market sentiment turned cautious,GSK seeks expanded EMA approval for Arexvy RSV vaccine amid...
Kalkine: FTSE Companies See hVIVO (LON:HVO) Shares Decline Sharply on High Volume
June 03, 2025 02:01 AM AEST| By Team Kalkine MediaHighlights,hVIVO shares experienced a significant drop in trading volume on the London Stock Exchange,The company’s latest earnings update and recent insider activity have drawn attention,Despite positive broker sentiment, the stock moved lower amid...
Kalkine: hVIVO plc (LON:HVO) Sees Sharp Share Price Decline Amid High Trading Volume – Impact on FTSE Companies
June 03, 2025 01:58 AM AEST| By Team Kalkine MediaHighlights,hVIVO plc (LON:HVO) shares dropped significantly in recent trading despite high trade volumes,The company operates in the pharmaceutical service and clinical research sector, specialising in human challenge trials,Recent insider transactio...
Kalkine: hVIVO Shares Slide Sharply Amid Surging Trading Volume – Impact on FTSE Companies
June 03, 2025 01:54 AM AEST| By Team Kalkine MediaHighlights,hVIVO plc (LON:HVO) experienced a notable decline in share price with a substantial increase in trading activity,The company’s financial ratios and earnings figures reflected recent market changes,Insider transactions and market performanc...
Kalkine: FTSE 100 Stocks Update – hVIVO (LON:HVO) Sees Sharp Drop in Trading Volume Activity
June 03, 2025 01:48 AM AEST| By Team Kalkine MediaHighlights,hVIVO (LON:HVO) shares traded significantly lower with a notable increase in volume,The company operates within the biotechnology sector and is listed on the FTSE AIM All-Share Index,Key financial metrics show strong return on equity and s...
Kalkine: hVIVO (LON:HVO) Stock Performance Amid Market Fluctuations
June 02, 2025 10:50 PM AEST| By Team Kalkine MediaHighlights,hVIVO (LON:HVO) experienced significant fluctuations in its stock price, trading at a notably lower level.,The company maintains a market cap and a price-to-earnings ratio in line with its sector.,hVIVO specializes in pharmaceutical servic...
Kalkine: hVIVO (LON:HVO) Shares Experience Significant Decline Amid Market Activity
June 02, 2025 10:48 PM AEST| By Team Kalkine MediaHighlights,hVIVO's stock price fell sharply during mid-day trading.,The company operates in pharmaceutical services, focusing on human challenge clinical trials.,Insider activity included the sale of a significant number of shares.,hVIVO (LON:HVO) op...
Kalkine: hVIVO (LON:HVO) Shares Slide Sharply Amid Heavy Volume – Impacts FTSE 100 Stocks Sentiment
June 02, 2025 10:45 PM AEST| By Team Kalkine MediaHighlights,hVIVO plc (LON:HVO), listed on the FTSE AIM All-Share Index, experienced a notable decline in share price,Trading volume surged significantly, far exceeding recent daily averages,Recent earnings update and share by a director noted in late...
Kalkine: hVIVO (LON:HVO) Faces Sharp Decline Amid Surge in Volume – ftse 100 futures Watch
June 02, 2025 10:38 PM AEST| By Team Kalkine MediaHighlights,hVIVO (LON:HVO) shares experienced a significant drop in the latest trading session,Trading volume spiked substantially above its typical daily average,Company continues operating within the pharmaceutical service and clinical trials secto...
Kalkine: Indivior to Exit London Exchange, Retain Nasdaq Listing Status – indexftse ukx Impact
June 02, 2025 09:59 PM AEST| By Team Kalkine MediaHighlights,Indivior PLC to delist from the London Stock Exchange while maintaining its Nasdaq listing,The pharmaceutical company will continue to trade under ticker INDV on Nasdaq,Delisting marks a shift in listing strategy, with the firm’s primary f...
Kalkine: FTSE 350 pharma firm (LSE:INDV) exits LSE for Nasdaq focus
June 02, 2025 09:01 PM AEST| By Team Kalkine MediaHighlights,FTSE 350 pharmaceutical company INDV.L confirms exit from London Stock Exchange,INDV.L to prioritise Nasdaq GS as its sole primary listing moving forward,Majority of INDV.L shareholders and trading activity now based in the United States,F...
Kalkine - FTSE 100: hVIVO (LON:HVO) Shares Drop Sharply Amid Increased Trading Activity
June 02, 2025 08:18 PM AEST| By Team Kalkine MediaHighlights,hVIVO (LON:HVO) experienced a significant drop in share price during recent trading activity, with trading volume rising substantially above average.,The company focuses on pharmaceutical services, primarily conducting human challenge tria...
Kalkine : Indivior’s Exit from London Exchange Impacts FTSE 100 Pharmaceutical Landscape
June 02, 2025 08:12 PM AEST| By Team Kalkine MediaHighlights,Indivior (LON:INDV) will cancel its secondary listing on the London Stock Exchange by the end of July.,The decision follows a decline in share price and a strategic focus on the Nasdaq.,The company cited cost reduction and lower liquidity...
Kalkine : FTSE 100 Pharmaceutical Firm Indivior to Exit London Stock Exchange Amid US Market Focus
June 02, 2025 07:50 PM AEST| By Team Kalkine MediaHighlights,Indivior (LON:INDV) plans to delist from the London Stock Exchange in July, citing alignment with its US-focused revenue and operations.,The pharmaceutical firm moved its primary listing to the Nasdaq last year, citing higher liquidity and...
Is IXICO Positioned to Transform Neurodegenerative Research on the FTSE AIM and fts100 Today?
May 20, 2025 10:31 PM AEST| By Team Kalkine MediaHighlights,IXICO reports increased revenue and gross profit amid continued contract growth,The company is rolling out advanced imaging tools for Parkinson's and related disorders,Cash reserves strengthened through fundraising, supporting product deve...
Can Poolbeg Pharma Overcome Biotech Hurdles with Breakthrough Therapies? | fts100 today
May 20, 2025 10:30 PM AEST| By Team Kalkine MediaHighlights,Poolbeg Pharma PLC raises new funding to progress two biopharmaceutical assets addressing inflammation and obesity.,POLB 001 is being developed as an oral therapy to manage cytokine release syndrome linked with cancer treatments.,An oral G...
What Do Creo Medical's Results Indicate About Its Role in the FTSE Index Healthcare Segment?
May 20, 2025 09:30 PM AEST| By Team Kalkine MediaHighlights,Core technology revenue showed significant year-over-year growth driven by device adoption,Divestment in the consumables unit brought in strategic capital and strengthened partnerships,Expansion in customer base reflects rising interest in...
How Is This FTSE Healthcare Stock Strengthening Its AI Strategy in Neuroimaging?
May 20, 2025 05:31 PM AEST| By Team Kalkine MediaHighlights,IXICO PLC reported a rise in revenues and gross margin, reflecting gains from its “Innovate, Lead, Scale” strategy.,The company secured a key contract in Huntington’s disease trials and expanded operations in key therapeutic areas.,Artific...
What’s Driving Poolbeg Pharma’s Latest Fundraising Plan on the FTSE AIM Index?
May 20, 2025 05:30 PM AEST| By Team Kalkine MediaHighlights,Poolbeg Pharma plans to raise funding through discounted share issuance and subscriptions to support clinical trials.,Proceeds will be used to advance programs in cancer immunotherapy and obesity treatment.,The company reported a strengthe...
What’s Driving Arecor’s Gains on the LSE as FTSE Prices Shift?
May 19, 2025 10:30 PM AEST| By Team Kalkine MediaHighlights,Arecor Therapeutics PLC (LSE:AREC) announced a development agreement with US-based Skye Bioscience focusing on an obesity drug formulation.,The collaboration employs Arecor’s Arestat technology to develop a higher concentration version of...
AI on the Rise: A Look at Top AI Companies and Their Stocks